Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,952.00
Bid: 2,951.00
Ask: 2,952.00
Change: 25.00 (0.85%)
Spread: 1.00 (0.034%)
Open: 2,900.00
High: 2,955.00
Low: 2,895.00
Prev. Close: 2,927.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio update and Capital Markets Seminar

23 Sep 2020 07:00

RNS Number : 7923Z
3i Group PLC
23 September 2020
 

 

Press release

23 September 2020

 

3i Group plc

Update on the portfolio and Capital Markets Seminar

 

3i Group plc ("3i" or "the Group") will be holding a Capital Markets Seminar via webcast today, involving presentations on our approach to ESG and responsible investment, as well as on Evernex and SaniSure, two of our recent Private Equity Investments. In addition, Simon Borrows, our Chief Executive, will provide an update on the portfolio, the key elements of which are outlined below. The seminar will start at 14.00 and the joining details are provided at the end of this press release. The presentation materials and a recording of the webcast will also be made available on our website.

We have now completed our September semi-annual portfolio company reviews for Private Equity, Infrastructure and Scandlines, which have reinforced our belief in the resilience and strength of earnings performance in the significant majority of our investments. The automotive sector remains challenged, and public health policy has prolonged the uncertainty for the travel sector. However, we continue to see strong momentum in portfolio companies exposed to medical technology and personal care products and very good recovery in our retail businesses, particularly in online, and of course in Action.

Action's impressive performance has continued with sales, EBITDA and cash generation above expectations for P7 (July), P8 (August) and P9 (September) to date. YTD sales at over €3.7 billion have now recovered to be approximately 8% ahead of last year with strong trading continuing across all geographies. We expect LTM EBITDA to the end of P9 to be approximately €575 million compared to €506 million at September last year and €491 million at the end of P4 this year. Cash generation has continued to be strong with a current cash balance of over €625 million after a €51 million repayment of the RCF. Action has now opened 88 stores in 2020 including its first five stores in the Czech Republic. Initial trading in the Czech Republic has been significantly ahead of expectations.

A live webcast of the seminar will be available at 14.00. To register for the webcast, please visit www.3i.com/investor-relations/capital-markets-presentations/2020.

 

- Ends-

 

 

For further information, contact:

 

3i Group plc

 

Silvia Santoro

Investor enquiries

 

Kathryn van der Kroft

Media enquiries

 

 

 

Tel: +44 20 7975 3258

Email: silvia.santoro@3i.com

 

Tel: +44 20 7975 3021

Email: kathryn.vanderkroft@3i.com

 

 

 

Notes to editors:

 

About 3i Group

 

3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core investment markets are northern Europe and North America.

 

For further information, please visit: www.3i.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBIGDCXSDDGGD
Date   Source Headline
6th Apr 201710:47 amRNSDirector Declaration
31st Mar 20171:50 pmRNSTotal Voting Rights
31st Mar 20171:50 pmRNSDirector/PDMR Shareholding
6th Mar 20179:45 amRNSDirector/PDMR Shareholding
3rd Mar 201710:00 amRNSCompletion of sale of 3i Debt Management
28th Feb 20172:30 pmRNSTotal Voting Rights
28th Feb 20172:26 pmRNSDirector/PDMR Shareholding
31st Jan 20174:21 pmRNSTotal Voting Rights
31st Jan 20174:21 pmRNSDirector/PDMR Shareholding
26th Jan 20177:00 amRNSQ3 performance update
25th Jan 20179:14 amRNSAdditional Listing
6th Jan 20174:23 pmRNSPortfolio Update
30th Dec 201611:52 amRNSTotal Voting Rights
30th Dec 201611:49 amRNSDirector/PDMR Shareholding
12th Dec 20162:14 pmRNSBlock listing Interim Review
30th Nov 20163:13 pmRNSTotal Voting Rights
30th Nov 20163:12 pmRNSDirector/PDMR Shareholding
22nd Nov 20162:10 pmRNSDirector/PDMR Shareholding
11th Nov 201612:48 pmRNSDirector/PDMR Shareholding
10th Nov 20162:02 pmRNSDoc re. 2016 Half Yearly Report
10th Nov 20167:00 amRNSHalf-year Report
31st Oct 20161:13 pmRNSTotal Voting Rights
31st Oct 20161:11 pmRNSDirector/PDMR Shareholding
25th Oct 20167:00 amRNSAgreement to sell Debt Management business
5th Oct 20163:13 pmRNSPortfolio Update
3rd Oct 20161:45 pmRNSDirector/PDMR Shareholding
30th Sep 20162:20 pmRNSTotal Voting Rights
30th Sep 20162:18 pmRNSDirector/PDMR Shareholding
22nd Sep 201610:39 amRNSDirector Declaration
7th Sep 20169:33 amRNSDirectorate Change
7th Sep 20169:30 amRNSInterest in bond buy-backs
31st Aug 20162:00 pmRNSTotal Voting Rights
31st Aug 20161:56 pmRNSDirector/PDMR Shareholding
9th Aug 20163:07 pmRNSDirector/PDMR Shareholding
9th Aug 20162:24 pmRNSDirector/PDMR Shareholding
4th Aug 201610:21 amRNSPurchase of Notes
2nd Aug 201611:58 amRNSDirector/PDMR Shareholding
29th Jul 20163:31 pmRNSTotal Voting Rights
29th Jul 20163:25 pmRNSDirector/PDMR Shareholding
28th Jul 20161:11 pmRNSDirector/PDMR Shareholding
27th Jul 20167:00 amRNSFY2017 Q1 Performance update
4th Jul 201611:40 amRNSPortfolio Update
30th Jun 20163:16 pmRNSResult of AGM
30th Jun 20163:12 pmRNSDoc re. AGM Resolutions
30th Jun 20163:11 pmRNSDirector/PDMR Shareholding
30th Jun 20162:50 pmRNSTotal Voting Rights
30th Jun 20162:46 pmRNSDirector/PDMR Shareholding
30th Jun 20167:10 amRNSAnnual General Meeting
30th Jun 20167:00 amRNSUpdate on Action valuation
13th Jun 20162:05 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.